Direct comparison
Allocation Concealment vs Blinding: Differences
Allocation concealment hides the next assignment from enrollers before it happens; blinding hides it afterward. Compare the biases and CONSORT items.
Written and maintained by CASRAI Editorial Board
Last updated
How do Allocation Concealment and Blinding (Masking) compare side by side?
The table below compares Allocation Concealment and Blinding (Masking) across 11 dimensions, from what it hides to how it is undermined in practice.
Side-by-side comparison
| Dimension | Allocation Concealment | Blinding (Masking) |
|---|---|---|
| What it hides | Which group the next enrolled participant will be assigned to | Which group a participant already assigned belongs to |
| When it operates | Before and at the moment of assignment | After assignment, for the duration of the trial (sometimes beyond) |
| Bias it protects against | Selection bias — the enroller steering participants toward an arm | Performance bias (differential care/behavior) and detection/ascertainment bias (differential outcome assessment) |
| Is it always achievable? | Yes — a logistics problem, solvable regardless of the intervention | No — often infeasible for surgery, physiotherapy, most behavioral/lifestyle interventions |
| Who is kept unaware | The person enrolling and assigning participants | Any combination of participants, clinicians, outcome assessors, analysts |
| Typical mechanisms | Central/telephone/web randomization, SNOSE (sequentially numbered opaque sealed envelopes), sequentially numbered coded containers, pharmacy-controlled randomization | Placebo/sham comparator, double-dummy design, identical coded drug packaging, independent blinded outcome assessment |
| CONSORT 2010 checklist item | Item 9 (alongside item 8, sequence generation) | Item 11 — a separate item entirely |
| Evidence when it fails | Inadequate/unclear concealment associated with larger, more variable effect estimates (Schulz & Grimes, Lancet 2002) | Lack of blinded outcome assessment: 36% exaggeration for binary outcomes, 68% for scale-measured outcomes, 27% for time-to-event outcomes (Hrobjartsson et al., BMJ 2012 / CMAJ 2013 / Int J Epidemiol 2014) |
| Can exist without the other? | Yes — an open-label trial can still have fully concealed allocation | Rare in the reverse direction — a foreseeable sequence undermines both at once |
| Wording you will see in papers | "Concealed allocation", "allocation was concealed", "concealment of allocation" - all mean the next assignment was hidden from the enroller | "Blinded", "masked", "double-blind" - should always say who was unaware (participants, clinicians, assessors, analysts) |
| How it is undermined in practice | Sealed envelopes opened early or held up to a light; central allocation is more secure but not immune, for example when staff keep lists of earlier allocations | Obvious side effects, distinguishable treatments, or an intervention that cannot be disguised |
Ask CASRAI · free to try
Ask about Allocation Concealment vs Blinding: Differences
2 free questions a day, no account.
An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.
Common questions
Common questions about Allocation Concealment vs Blinding (Masking)
Are allocation concealment and blinding the same thing?
+
No. Allocation concealment hides the upcoming assignment from whoever enrolls participants, before it happens, and protects against selection bias. Blinding hides an assignment that has already happened, from participants and/or study staff, and protects against performance and detection bias. They are separate CONSORT 2010 checklist items (9 and 11) and separate methodological safeguards, even though the terms are frequently used interchangeably in practice.
Can a trial have allocation concealment without blinding?
+
Yes, and this is common. An open-label (unblinded) randomized controlled trial — for example, a pragmatic trial comparing surgery to physiotherapy, where the intervention cannot be disguised — can still use central randomization or another concealment mechanism so the enrolling investigator never knows the next assignment in advance. Concealment and blinding are independent design choices; only concealment is available in every trial.
If a trial reports being "double-blind," does that mean allocation was concealed?
+
Not necessarily, and this is exactly the conflation that causes confusion. "Double-blind" describes who was kept unaware of the assignment after randomization; it says nothing about how (or whether) the assignment sequence was concealed from the enrolling investigator beforehand. A complete methods section reports both, separately, per CONSORT 2010 items 9 and 11.
Which failure is more consequential for a trial’s validity?
+
Both matter, but they are not interchangeable risks. A concealment failure introduces selection bias at the point of enrollment, which cannot be corrected after the fact by anything done later in the trial. A blinding failure introduces performance or detection bias during the trial, which can sometimes be partially mitigated — for example, by using a blinded outcome assessor even when participants and treating clinicians cannot be blinded.
What is allocation concealment?
+
Allocation concealment keeps the assignment of participants to treatment groups secret until the moment of assignment, so that nobody enrolling participants can use knowledge of the next allocation. When it is weak or missing, selection bias can result. Common mechanisms are central randomization, sequentially numbered opaque sealed envelopes, sequentially numbered containers and pharmacy-controlled randomization.
What does "concealed allocation" or "allocation was concealed" mean?
+
It means the allocation sequence was hidden from the people recruiting and assigning participants until each participant was irrevocably assigned. It is the same safeguard as allocation concealment, phrased as a property of the trial rather than of the method, and it says nothing about whether participants or staff were blinded afterwards.
Is allocation concealment the same as randomization?
+
No. Randomization generates an unpredictable allocation sequence (CONSORT item 8); allocation concealment protects that sequence from being foreseen or tampered with by the people enrolling participants (item 9). A properly randomized sequence that is posted openly or kept in transparent envelopes is randomized but not concealed.
Is allocation concealment the same as blinding?
+
No. Concealment hides the next assignment from the enroller before it happens; blinding hides an assignment that has already happened from participants, clinicians, assessors or analysts. Concealment is always possible, while blinding sometimes is not.







